Exhausted CD4+ T Cells during Malaria Exhibit Reduced mTORc1 Activity Correlated with Loss of T-bet Expression

J Immunol. 2020 Sep 15;205(6):1608-1619. doi: 10.4049/jimmunol.2000450. Epub 2020 Aug 17.

Abstract

CD4+ T cell functional inhibition (exhaustion) is a hallmark of malaria and correlates with impaired parasite control and infection chronicity. However, the mechanisms of CD4+ T cell exhaustion are still poorly understood. In this study, we show that Ag-experienced (Ag-exp) CD4+ T cell exhaustion during Plasmodium yoelii nonlethal infection occurs alongside the reduction in mammalian target of rapamycin (mTOR) activity and restriction in CD4+ T cell glycolytic capacity. We demonstrate that the loss of glycolytic metabolism and mTOR activity within the exhausted Ag-expCD4+ T cell population during infection coincides with reduction in T-bet expression. T-bet was found to directly bind to and control the transcription of various mTOR and metabolism-related genes within effector CD4+ T cells. Consistent with this, Ag-expTh1 cells exhibited significantly higher and sustained mTOR activity than effector T-bet- (non-Th1) Ag-expT cells throughout the course of malaria. We identified mTOR to be redundant for sustaining T-bet expression in activated Th1 cells, whereas mTOR was necessary but not sufficient for maintaining IFN-γ production by Th1 cells. Immunotherapy targeting PD-1, CTLA-4, and IL-27 blocked CD4+ T cell exhaustion during malaria infection and was associated with elevated T-bet expression and a concomitant increased CD4+ T cell glycolytic metabolism. Collectively, our data suggest that mTOR activity is linked to T-bet in Ag-expCD4+ T cells but that reduction in mTOR activity may not directly underpin Ag-expTh1 cell loss and exhaustion during malaria infection. These data have implications for therapeutic reactivation of exhausted CD4+ T cells during malaria infection and other chronic conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology*
  • Cellular Senescence
  • Gene Expression Regulation
  • Glycolysis
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Immune Tolerance
  • Immunologic Memory
  • Interferon-gamma / metabolism
  • Interleukin-27 / metabolism
  • Lymphocyte Activation
  • Malaria / immunology*
  • Malaria / therapy
  • Mechanistic Target of Rapamycin Complex 1 / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Plasmodium yoelii / physiology*
  • T-Box Domain Proteins / genetics
  • T-Box Domain Proteins / metabolism*
  • Th1 Cells / immunology*

Substances

  • Immune Checkpoint Inhibitors
  • Interleukin-27
  • T-Box Domain Proteins
  • T-box transcription factor TBX21
  • Interferon-gamma
  • Mechanistic Target of Rapamycin Complex 1